Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: enzalutamide
Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 3
The first part of this article is here. The exclusive license that UCLA granted to Medivation meets the requirements for an assignment of the subject invention. The license grants substantially all rights in the subject invention (to all compounds for … Continue reading
Posted in Bayh-Dole
Tagged enzalutamide, KEI, march-in, patent rights clause, subject invention, UCLA, Xtandi
Comments Off on Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 3
Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 2
The first part of this article is here. To explore these issues, let’s take a look at Xtandi, a prostate cancer drug that has received press recently in the debate over high drug prices. Xtandi sells in the U.S. for … Continue reading
Posted in Bayh-Dole
Tagged enzalutamide, march-in, Medivation, patent rights clause, Pfizer, subject invention, UCLA, Xtandi
Comments Off on Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 2